These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 14240726
1. METABOLISM OF 6-MERCAPTOPURINE RIBONUCLEOSIDE BY EHRLICH ASCITES CARCINOMA CELLS. PATERSON AR, SUTHERLAND A. Can J Biochem; 1964 Oct; 42():1415-23. PubMed ID: 14240726 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside. Paterson AR, Wang MC. Can J Biochem; 1970 Jan; 48(1):79-83. PubMed ID: 5512546 [No Abstract] [Full Text] [Related]
6. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE. ATKINSON MR, MURRAY AW. Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250 [Abstract] [Full Text] [Related]
7. THE METABOLISM OF 9-ARABINOSYL-6-MERCAPTOPURINE IN NORMAL AND NEOPLASTIC TISSUES. KIMBALL AP, LEPAGE GA, BOWMAN B. Can J Biochem; 1964 Dec; 42():1753-68. PubMed ID: 14241609 [No Abstract] [Full Text] [Related]
8. THE ROLE OF PI IN THE CONTROL OF GLYCOLYSIS IN ASCITES TUMOR CELLS. WU R. Biochem Biophys Res Commun; 1965 Feb 03; 18():402-8. PubMed ID: 14300756 [No Abstract] [Full Text] [Related]
9. MECHANISM OF ACTION OF GLUCOSE AND PYRIMIDINE NUCLEOSIDES ON (14C)FORMATE UTILIZATION BY EHRLICH ASCITES CELLS. HERSCOVICS A, JOHNSTONE RM. Biochim Biophys Acta; 1964 Nov 15; 91():365-73. PubMed ID: 14254007 [No Abstract] [Full Text] [Related]
11. Resistance to 6-mercaptopurine. II. The synthesis of thioinosinate in a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma. PATERSON AR. Can J Biochem Physiol; 1962 Feb 15; 40():195-206. PubMed ID: 14484318 [No Abstract] [Full Text] [Related]
12. Resistance to 6-mercaptopurine. I. Biochemical differences between the Ehrlich ascites carcinoma and a 6-mercaptopurine-resistant subline. PATERSON AR, HORI A. Can J Biochem Physiol; 1962 Feb 15; 40():181-94. PubMed ID: 14484317 [No Abstract] [Full Text] [Related]
13. Resistance to 6-mercaptopurine. III. Deletion of a 5'-nucleotidase in a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma. PATERSON AR, HORI A. Can J Biochem Physiol; 1963 Jun 15; 41():1339-48. PubMed ID: 13941819 [No Abstract] [Full Text] [Related]
14. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. REGELSON W, HOLLAND JF, FREI E, GOLD GL, HALL T, KRANT M, MILLER SO. Cancer Chemother Rep; 1964 Mar 15; 36():41-8. PubMed ID: 14152273 [No Abstract] [Full Text] [Related]
15. Inhibition of purine biosynthesis de novo and of Ehrlich ascites tumor cell growth by 6-methylmercaptopurine ribonucleoside. Shantz GD, Fontenelle LJ, Henderson JF. Biochem Pharmacol; 1972 Apr 15; 21(8):1203-6. PubMed ID: 5034201 [No Abstract] [Full Text] [Related]
16. THE SYNTHESIS OF EXTRACELLULAR RIBONUCLEOSIDES BY ASCITES TUMOR CELLS IN VITRO. PATERSON AR. Can J Biochem; 1965 Feb 15; 43():257-69. PubMed ID: 14325976 [No Abstract] [Full Text] [Related]
17. INHIBITION OF RIBONUCLEIC ACID AND DEOXYRIBONUCLEIC ACID SYNTHESIS IN EHRLICH ASCITES CELLS BY CORDYCEPIN-N1-OXIDE. FREDERIKSEN S. Biochim Biophys Acta; 1963 Nov 22; 76():366-71. PubMed ID: 14097399 [No Abstract] [Full Text] [Related]
19. ACCUMULATION OF DEOXYADENOSINE PHOSPHATES IN ASCITES TUMOR CELLS UNDER DIFFERENT EXPERIMENTAL CONDITIONS. KLENOW H. Acta Unio Int Contra Cancrum; 1964 Apr 27; 20():1021-2. PubMed ID: 14274683 [No Abstract] [Full Text] [Related]
20. [ON THE EFFECT OF DESOXYRIBONUCLEOSIDES ON THE INCORPORATION OF RADIOACTIVE PHOSPHATE IN DNA-NUCLEOTIDES IN ASCITES TUMOR CELLS IN VITRO]. LANGEN P, LISS E. Biochem Z; 1963 Jul 10; 337():360-5. PubMed ID: 14046120 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]